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PTH(1-34), also known as Teriparatide, is an active anabolic drug used in the 
treatment of some forms of osteoporosis and occasionally exploited to speed fracture 
healing. The effect of such therapies are dependent on the type of administration, in 
fact it has been largely demonstrated that a short administration of Teriparatide (also 
called intermittent) increases the bone mass, meanwhile a long administration of the 
same agent (known as continuous) leads to an increased resorption.
The molecular reason why the type of administration is so critical for the fate of 
the bone remodeling is still largely unknown but it is probably due to the fact that 
it affects several signaling pathways and alters the biological activity of a cohort of 
cells: osteoblasts, lining cells, osteoclasts, and osteocytes. In the present work, we 
firstly focused the attention on molecular events induced by intermittent vs continu-
ous Teriparatide treatment in a well-known osteocytes in vitro model, the MLO-Y4 
cells. By the use of a gene array platform, we found many molecules upregulated or 
downregulated depending on the the temporal administration modes, suggesting that 
the drug affects in diverse manner the osteocytes related signaling pathways. In par-
ticular, we paid attention to Wisp-2, a protein of the Wnt pathway that has been dem-
onstrated to be able to interact and influence the differentiation of osteoblasts into 
osteocytes and their mineralization. Secondly, through the mineralization assay, we 
analyzed the functional effects, involving the differentiation of osteoblast IDG-SW3 
cell line, upon the conditioning culture with MLO-Y4 medium, that were pre-treated 
with short and long time administration of Teriparatide. These findings, consistent 
with the crucial role performed by osteocytes on osteoblast differentiation, clarify the 
molecular events downstream the short treatment with Teriparatide, suggesting that 
the perturbation of certain signaling patwhays, such as the Wnt pathway, is crucial 
for the positive regulation of bone formation. 
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